Glucocorticoids have been used as treatments against a number of diseases, especially autoimmune/ inflammatory conditions in which the immune system is overactive. These treatments have varying degrees of responsiveness among individuals and in different tissues (including brain); therefore, it is important to determine what could account for these differences. In this study, we evaluated expression of stress hormone receptors in immune cells from lymphoid and non-lymphoid tissues (including brain) as a possible explanation. We analyzed leukocytes (CD45 + ) in kidney, liver, spleen, and thymus tissues from healthy mice for expression of the receptor for stress hormone (glucocorticoid-GR) as well as other steroid hormones (androgen-AR, progesterone-PR) and found that all tissues expressed these steroid hormone receptors but with varying patterns. To determine whether tissue-specific differences were related to immune cell composition, we examined steroid hormone receptor expression in T lymphocytes from each of these tissues and found similar patterns of expression in these cells regardless of tissue source. Because glucocorticoids can also impact brain function, we further examined expression of the stress hormone receptor in brain tissue and found GR expressed in immune cells at this site. In order to investigate the potential impact in an area of neuropathology, we utilized a mouse model of West Nile Virus (WNV). We observed pathological changes in brains of WNV-infected animals and T lymphocytes in the areas of inflammation; however, these cells did not express GR. These data indicate that tissuespecific differences in steroid hormone receptor expression by immune cells could determine responsiveness to steroid hormone treatment.
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Introduction
Glucocorticoids (GCs) are powerful inhibitors of immune responses and serve a regulatory function by preventing the immune system from going awry and causing excessive damage within tissues (Adcock, 2003) . Pharmacological doses limit immune responses by inhibiting pro-inflammatory cytokine/chemokine secretion, down-regulating activation/adhesion molecule expression on cell surfaces, and inducing apoptosis in immune cells (Evans-Storms and Cidlowski, 1995; Franchimont et al., 2000; Schleimer, 2004) . They can also inhibit metabolism of arachidonic acid to interfere with production of immune-stimulating prostaglandins and leukotrienes (Pitzalis et al., 2002; Tuckermann et al., 2007) . Glucocorticoids and other steroid hormones have also been shown to modify adaptive immune responses (Kirwan et al., 1999) , such as induction of T cell apoptosis and a shift in cytokine responses from T H 1 towards T H 2 (Schaaf et al., 2005) . Because of their strong impact on immune cells, glucocorticoids are commonly used for treatments of a number of autoimmune/inflammatory disorders (Kirwan et al., 1999) ; however, under some conditions, resistance to glucocorticoids has been reported and related to several mechanisms-including reduced number of glucocorticoid receptors (GR) (Adcock and Barnes, 2008) .
Glucocorticoids (GCs) are produced following activation of the hypothalamic-pituitary-adrenal (HPA) axis (Webster and Sternberg, 2004) . Inflammatory and stress-related stimuli trigger the hypothalamus to release corticotropin-releasing hormone (CRH) that leads to adrenocorticotropin hormone (ACTH) secretion from the pituitary and subsequent GC release by adrenal glands. They can also limit their own production via a feedback mechanism on the brain (Noguchi et al., 2010) . GCs primarily regulate cell function through binding of the glucocorticoid receptor (GR), a member of the steroid hormone receptor superfamilyintracellular receptors that predominantly act as transcription factors; and previous reports have shown glucocorticoid effects on lymphocyte development were dependent on expression of 0889-1591/$ -see front matter Published by Elsevier Inc. doi:10.1016/j.bbi.2010.11.003
